請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/45604
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 蘇燦?(Tsann-Juu Su) | |
dc.contributor.author | Kai-Li Chen | en |
dc.contributor.author | 陳凱麗 | zh_TW |
dc.date.accessioned | 2021-06-15T04:29:52Z | - |
dc.date.available | 2009-09-15 | |
dc.date.copyright | 2009-09-15 | |
dc.date.issued | 2009 | |
dc.date.submitted | 2009-08-19 | |
dc.identifier.citation | 中文文獻
台灣癌症登記統(無日期).癌症發生率與死亡率.2009年7月23日取自 http://crs.cph.ntu.edu.tw/uploadimages/Y95-C179_84.pdf77 王佩芬(2001).重新說故事—子宮頸抹片檢查.未發表的碩士論文,新竹:清華大學社會學研究所。 余玉眉、田聖芳、蔣欣欣(1994).質性研究—田野研究法於護理學之應用.台北:巨流。 余玉眉、蔣欣欣、陳月枝、蘇燦煮、劉玉秀(1999).質性研究資料的量化及詮釋--從研究例證探討臨床護理研究方法與認識學第二部分:研究例證之分析與詮釋.護理研究,7 (4),378-392。 吳香達(2003).子宮頸癌系列報導-壹、手術治療•中華民國婦癌醫學雜誌,1,2-22。 吳秀嬌(2003).照顧一位子宮頸癌患者接受根治性手術的護理經驗.長庚護理, 14(3),323-329。 林惠如、李慈音(2004).中年期之健康照護:生病經驗之衝擊—以癌症為例.護理雜誌,51(1),30-34。 林晏如(2006).全民健保下之預防醫療照護需求研究:婦女子宮抹片檢查之利用.未發表的博士論文.台北:政治大學。 林尹霈、陳玉敏(2006).危機理論的應用:以一位初次獲知診斷之癌症病患為例.長庚護理,17(1),49-55。 高淑清(2007).深度訪談.高雄:清江學習中心。 唐秀治、林玉娟、陳秋慧(2002).癌症化學治療護理.台北:匯華。 洪秀貌、林麗娟(2008).一位癌症診斷初期患者不確定感的護理經驗.高雄護理雜誌,25(1),34-47。 許麗珠(2006).放射線治療的發展與臨床應用之專題報導.腫瘤護理雜誌,6(2),65-73。 許逸欣、張文君、許博欽(2004).子宮頸癌.於周松男總校閱,婦產科學精要(1 版,125-133頁).台北:藝軒。 梁頌文(2005).子宮頸癌放射線治療之應用.高雄榮總醫訊, 8(11),6。 舒曼姝、蔡昌雄(2004).與癌症共存–––癌症病人對疾病的因應.腫瘤護理雜誌,3(2),19-28。 黃秀英(2002).癌症放射線治療及護理.於陳敏鋑、趙子傑、黃秀英、陳秋慧、陳瑞儀、胡文郁、鄭春秋、周繡玲、許麗株、楊克平、顧乃平等合著,癌症護理學學(1版,95-119頁).台北:華杏。 黃玉苹、李選、Kellett,U.M., John,W.S.,(2006).剖析現象學論點與其在護理研究中之應用.護理雜誌,53(2),49-57。 彭淑惠、黃珊(2002)•一位鼻咽癌病患在治療期間生理、心理問題及因應行為之探討•長庚護理,13(2),175-181。 童寶玲(2003).「六分鐘護一生」就夠嗎?—子宮頸癌篩選.台大醫網,7月,13-15。 童寶玲(2007).如何預防子宮頸癌談子宮頸癌疫苗.健康世界,255,11-13。 曾月霞(2003)•中年人健康行為之探討•護理雜誌,51(1),20-24。 曾光毅、曾嵩智(2004)•現階段子宮頸癌的預防與治療•基層醫學,19(9),212-218。 楊靜雯、梁雲、林佑樺、王秀仁、陳惠君(1998).子宮頸癌病患接受體腔內近接放測至療時疼痛緩解效果之探討.護理雜誌,45(1), 29-37。 楊鎧玉、陳靜敏、林佳靜、李龍騰 (2004) .臺北市子宮頸抹片檢查陽性個案求醫行為相關因素之探討.腫瘤護理雜誌,3(2), 1-18. 熊佩偉、許文林(1996).中晚期子宮頸癌放射線合併化學治療之近況.核研季刊, 20,28-31。 葉樹人、陳慧祺、黃立民(2007).子宮頸癌疫苗.台灣醫學,11(6), 649-654。 廖彩鈺、羅琦(2006).協助一位鼻咽癌病患接受同步化學放射治療的護理經驗.高雄護理雜誌,23(2), 21-33。 郭素娥、邱飄逸(1999).不確定感的分析與應用—照顧兩位疾病診斷期病患之護理經驗.榮總護理,1(3),275—285。 賴裕和(1998)•門診接受化學治療病人之症狀困擾及居家護理需求探討•護理研究,6(4),279-289。 陳月枝、劉淑娟、穆佩芬、造可是、盧孶艷、徐亞瑛(2000).質性護理研究方法. 台北:護望。 陳馥萱(1997).一位子宮頸原位癌患者於診斷及治療過程中之有效因應行為.護理雜誌,44(6),41-51。 陳馥萱(1997).初次獲知子宮頸抹片檢查異常之婦女於確定診斷前之經驗歷程與因應行為.未發表的碩士論文,台北:台灣大學醫學院護理研究所。 陳昭誠(2001).慢談子宮頸癌與性.聲洋防癌之聲秋季號,27-29。 陳祈安(2003)•子宮頸癌之治療•臺灣醫學,7(6),954-987。 陳珮娥、湯玉英(2005)•因應之概念分析•護理雜誌,52(2),61-65。 陳秋惠(2002).癌症化學治療與護理.於陳敏鋑、趙子傑、黃秀英、陳秋慧、陳瑞儀、胡文郁、鄭春秋、周繡玲、許麗株、楊克平、顧乃平等合著,癌症護理學(1版,120-155頁).台北:華杏。 陳慈怡、李嬿如、游山林、陳建仁、謝長堯、陳素秋(2005)•全民健保實施前後影響子宮頸抹片篩檢之因素及成果•臺灣公共衛生雜誌,24(5),440—451。 陳雅萍、葉淑惠、龔福財、何美瑤(2006)•子宮頸癌住院病人症狀困擾、憂鬱及生活品質之相關性研究•實證護理,3(2),89—97。 陳玉萍、曾振淦、湯國政、洪志宏、曾雁明(2003)•放射治療之癌患對食物禁忌的調查•放射治療與腫瘤學,10(3),137—140。 顏上惠(2003)•子宮頸癌系列報導-貳、放射線治療•中華民國婦癌醫學雜誌,2,1—14。 蔡菊蘭、洪明玉(2004).生殖系統的解剖生理.於鍾聿琳總校閱,簡明產科護理(5版,35-81頁).台北:華杏。 蔡宜蓁、梁蕙芳(2008)• 協助一位子宮頸癌患者接受根治性手術之護理經驗•長庚護理,19(1),99—108。 鄭惠鑫(2001)• 一位子宮頸癌病患之護理經驗•長庚護裡,12(3),246—251。 英文文獻 Abayomi, J., Kirwan, J., Hackett, A., & Bagnall, G. (2005). A study to investigate women's experiences of radiation enteritis following radiotherapy for cervical cancer. Journal of Human Nutrition & Dietetics, 18(5), 353–363. Alberts, D. S., & Mason-Liddil, N. (1989). The role of cisplatin in the management of advanced squamous cell cancer of the cervix. Seminars in oncology, 16(4 Suppl 6), 66–78. Almeida-Parra, Z., Peñalver, M., & Mendez, L. E. (2006). Cervical cancer. In E. J. Bieber, J. S. Sanfilippo, I. R. Horowitz & (Eds.), Clinical Gynecology (1 ed., pp. 652-663). Canada: Elsevier. Bonomi, P., Blessing, J. A., Stehman, F. B., DiSaia, P. J., Walton, L., & Major, F. J. (1985). Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: A Gynecologic Oncology Group study. Journal of Clinical Oncology, 3(8), 1079–1085. Chen, C. A., & Hsieh, C. Y. (2004). Recent advances and problems in primary therapy for cervical cancer in Taiwan. Journal of the Formosan Medical Association, 103(7), 511–518. Chen, H.-C., Wan Leung, S., Wang, C.-J., Sun, L.-M., Fang, F.-M., Huang, E.-Y., et al. (1998). Local vaginal anesthesia during high-dose-rate intracavitary brachytherapy for cervical cancer. International Journal of Radiation Oncology Biology Physics, 42(3), 541–544. Chen, S. W., Liang, J. A., Hung, Y. C., Yeh, L. S., Chang, W. C., Lin, W. C., et al. (2006). Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications. International Journal of Radiation Oncology, Biology, Physics, 66(5), 1370–1377. Eifel, P. J. (2006). Chemoradiotherapy in the treatment of cervical cancer. Seminars in Radiation Oncology, 16(3), 177–185. Eifel, P. J. (2006). Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer. Nature Clinical Practice Oncology, 3(5), 248–255. Fieler, V. K. (1997). Side effects and quality of life in patients receiving high-dose rate brachytherapy. Oncology Nursing Forum, 24, 545–553. Grogan, M., Thomas, G. M., Melamed, I., Wong, F. L., Pearcey, R. G., Joseph, P. K., et al. (1999). The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer, 86(8), 1528–1536. Hinds, G., & Moyer, A. (1997). Support as experienced by patients with cancer during radiotherapy treatments. Journal of Advanced Nursing, 26(2), 371–379. Ikushima, H., Osaki, K., Furutani, S., Yamashita, K., Kawanaka, T., Kishida, Y., et al. (2006). Chemoradiation therapy for cervical cancer: Toxicity of concurrent weekly cisplatin. Radiation Medicine, 24(2), 115–121. J. Abayomi, J. K. A. H. G. B. (2005). A study to investigate women's experiences of radiation enteritis following radiotherapy for cervical cancer. Journal of Human Nutrition & Dietetics, 18(5), 353–363. Jampolis, S., Andras, E. J., & Fletcher, G. H. (1975). Analysis of sites and causes of failures of irradiation in invasive squamous cell carcinoma of the intact uterine cervix. Radiology, 115(3), 681–685. Jordan, L. N., & Mantravadi, R. V. P. (1991). Nursing care of the patient receiving high dose rate brachytherapy.Oncology Nursing Forum, 18(7), 1167–1171. Kamer, S., Ozsaran, Z., Celik, O., Bildik, O., Yalman, D., B l kba i, Y., et al. (2007). Evaluation of anxiety levels during intracavitary brachytherapy applications in women with gynecological malignancies. European journal of gynaecological oncology, 28(2), 121–124. Keys, H. M., Bundy, B. N., Stehman, F. B., Muderspach, L. I., Chafe, W. E., Suggs, C. L., et al. (1999). Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. New England Journal of Medicine, 340(15), 1154–1161. King, K. B., Nail, L. M., Kreamer, K., Strohl, R. A., & Johnson, J. E. (1985). Patients'descriptions of the experience of receiving radiation therapy. Oncology Nursing Forum, 12(4), 55–61. Klee, M., Thranov, I., & Machin, D. (2000). Life after radiotherapy: the psychological and social effects experienced by women treated for advanced stages of cervical cancer. Gynecologic Oncology, 76(1), 5–13. Koh, W. J. (2003). Controversies in the radiotherapeutic management of cervical cancer. Journal of Clinical Oncology, 21(10), 218–223. Loizzi, V., Cormio, G., Loverro, G., Selvaggi, L., Disaia, P. J., & Cappuccini, F. (2003). Chemoradiation: A new approach for the treatment of cervical cancer. International Journal of Gynecological Cancer, 13(5), 580–586. Long, H. J. I. I. I. M. D., Laack, N. N. I. M. D. M. S., & Gostout, B. S. M. D. (2007). Prevention, diagnosis, and treatment of cervical cancer. Mayo Clinic Proceedings, 82(12), 1566–1574. Lorvidhaya, V., Tonusin, A., Changwiwit, W., Chitapanarux, I., Srisomboon, J., Wanwilairat, S., et al. (2000). High-dose-rate afterloading brachytherapy in carcinoma of the cervix: an experience of 1992 patients. International Journal of Radiation Oncology*Biology*Physics, 46(5), 1185–1191. Morris, M., Eifel, P. J., Lu, J., Grigsby, P. W., Levenback, C., Stevens, R. E., et al. (1999). Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. New England Journal of Medicine, 340(15), 1137–1143. Nag, S., Chao, C., Erickson, B., Fowler, J., Gupta, N., Martinez, A., et al. (2002). The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. International Journal of Radiation Oncology, Biology, Physics, 52(1), 33–48. Nagy, V., Todor, N., Coza, O., Ordeanu, C., & Ghilezan, N. (2007). Quality of life and treatment related toxicity in 335 patients with locally advanced cervical carcinoma treated by two chemoradiation regimens. Journal of B.U.On., 12(3), 389–394. Nail, L. M., King, K. B., & Johnson, J. E. (1986). Coping with radiation treatment for gynecologic cancer: mood and disruption in usual function. Journal of Psychosomatic Obstetrics & Gynecology, 5(4), 271–281. Nishimura, Y. (2004). Rationale for chemoradiotherapy. International Journal of Clinical Oncology, 9(6), 414–420. Obermair, A., Cheuk, R., Horwood, K., Janda, M., Bachtiary, B., Schwanzelberger, B., et al. (2001). Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma. Cancer, 92(4)2383–2388. Padilla, G., & Ropka, M. E. (2005). Quality of life and chemotherapy-induced Neutropenia. Cancer Nursing, 28(3), 167–171. Pearcey, R., Brundage, M., Drouin, P., Jeffrey, J., Johnston, D., Lukka, H., et al. (2002). Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. Journal of Clinical Oncology, 20(4), 966–972. Pearcey, R., Miao, Q., Kong, W., Zhang-Salomons, J., & Mackillop, W. J. (2007). Impact of Adoption of Chemoradiotherapy on the Outcome of Cervical Cancer in Ontario: Results of a Population-Based Cohort Study. Journal of Clinical Oncology , 25(17), 2383–2388. Petereit, D. G., Sarkaria, J. N., Chappell, R., Fowler, J. F., Hartmann, T. J., Kinsella, T. J., et al. (1995). The adverse effect of treatment prolongation in cervical carcinoma.[see comment]. International Journal of Radiation Oncology, Biology, Physics, 32(5), 1301–1307. Peters, W. A., 3rd, Liu, P. Y., Barrett, R. J., 2nd, Stock, R. J., Monk, B. J., Berek, J. S., et al. (2000). Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in highrisk earlystage cancer of the cervix. Journal of Clinical Oncology, 18(8), 1606–1613. Poti, Z., Patyanik, M., & Nemeskeri, C. (2006). Radiochemotherapy of cervical carcinoma. Orvosi Hetilap, 147(28), 1315–1320. Rollison, B., & Strang, P. (1995). Pain, nausea and anxiety during intra-uterine brachytherapy of cervical carcinomas. Supportive Care in Cancer, 3(3), 205–207. Rose, P. G., Bundy, B. N., Watkins, E. B., Thigpen, J. T., Deppe, G., Maiman, M. A., et al. (1999). Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. New England Journal Medicine, 340(15), 1144–1153. Rustoen, T. R. N. P. D., & Wiklund, I. P. D. (2000). Hope in newly diagnosed patients with cancer. Cancer Nursing, 23(3), 214–219. Serkies, K., & Jassem, J. (2004). Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: A report on patient compliance and acute toxicity. International Journal of Radiation Oncology Biology Physics, 60(3), 814–821. Smith, M. D., Todd, J. G., & Symonds, R. P. (2002). Analgesia for pelvic brachytherapy. British Journal of Anaesthesia, 88(2), 270–276. So, W. K.-W., & Chui, Y.-Y. (2007). Women's experience of internal radiation treatment for uterine cervical cancer. Journal of Advanced Nursing, 60(2), 154–161. Stehman, F. B., Bundy, B. N., DiSaia, P. J., Keys, H. M., Larson, J. E., & Fowler, W. C. (1991). Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer, 67(11), 2776–2785. Velji, K., & Fitch, M. (2001). The experience of women receiving brachytherapy for gynecologic cancer. Oncology Nursing Forum, 28(4), 743–751. Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.[see comment]. Journal of Pathology, 189(1), 12–19. Warnock, C. (2005). Patients' experiences of intracavitary brachytherapy atreatment for gynecological cancer.European Journal of Oncology Nursing, 9, 44–55. Whitney, C. W., Sause, W., Bundy, B. N., Malfetano, J. H., Hannigan, E. V., Fowler, W. C., Jr., et al. (1999). Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. Journal of Clinical Oncology, 17(5), 1339–1348. Wong, L. C., Choo, Y. C., Choy, D., Sham, J. S. T., & Ma, H. K. (1989). Long-term follow-up of potentiation of radiotherapy by cis-platinum in advanced cervical cancer. Gynecologic Oncology, 35(2), 159–163. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/45604 | - |
dc.description.abstract | 子宮頸原位癌可百分之百治癒,但有些婦女初次診斷時疾病已發展至晚期。局部晚期子宮頸癌自1999年開始以同步化學放射線治療為標準治療,此新的治療方式改善患者的存活率,同時造成患者身心與生活上的衝擊。
本研究目的為深入探討子宮頸癌婦女接受同步化學放射線治療期間的生活經驗,採質性研究設計,田野研究法,於台北市某醫學中心以立意取樣的方式,選取接受同步化學放射線治療之子宮頸癌婦女,共七位。研究者以參與式觀察,一面提供照護,一面以會談法,於個案接受治療約兩個月期間收集資料。資料參考現象學資料分析,呈現子宮頸癌患者於此期間的真實經驗與感受。 本研究結果發現子宮頸癌患者於接受同步化學放射線治療期間的生活經驗, 包括五個類目:一、面對確立診斷的複雜情緒,二、惶恐眼前即將進行一場硬仗,三、陷入第一段展開的苦戰,四、跨入第二段最嚴厲的苦戰,五、欣喜打完一場艱困硬戰卻心悸猶存。 本研究結果可提供照顧此類婦女之相關健康照顧者了解子宮頸癌婦女於接受同步化學放射線治療期間的生活經驗,做為醫療計畫與臨床護理指導之參考。 | zh_TW |
dc.description.abstract | Cervical cancer could be totally healed if it is diagnosed in cervical carcinoma in situ stage. However, many patients did not obtain confirmed diagnosis until the cancer proceeds to its advance stage. Concurrent chemoradiotherapy has become the standard treatment of local advance cervical cancer since 1999. The new treatment improved patient’s survival but they therefore suffer from a series of concurrent chemoradiotherapy treatment procedures which cause them enormous physical and psychological impacts.
The purpose of this study was to explore lived experiences of patients receiving concurrent chemoradiotherapy treatment in a medical center in Taipei City. Qualitative research methods were used to figure out patients’ profound experiences. Seven patients receiving concurrent chemoradiotherapy treatment were recruited by using purposive sampling strategy. As an observer-as-participant, the author took care of the subjects, observed the process while patients receiving treatments, and talked to patients in order to understand their explicit and implicit experiences. All the data were densely described and analyzed inductively. Five main themes were identified as the followings: (1)complicated emotions while the cancer diagnosis became apparent; (2) strong fear of the coming battles with cancer treatments; (3) suffering from the first stage treatment; (4) experiencing the most painful stage of the treatments; and (5) ongoing fright after the treatment procedures. The staged and anguished experiences among women with cervical cancer and receiving concurrent chemoradiotherapy treatment were uncovered in this study. Implications and suggestions for health professionals were made based on the findings to improve the quality of care for their patients. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T04:29:52Z (GMT). No. of bitstreams: 1 ntu-98-R94426020-1.pdf: 1248979 bytes, checksum: d9068bd535e2237d2bdf3b65e0e4a1e9 (MD5) Previous issue date: 2009 | en |
dc.description.tableofcontents | 誌謝.....................................................................................................................i
中文摘要............................................................................................................ii 英文摘要...........................................................................................................iii 圖目錄..............................................................................................................vii 表目錄..............................................................................................................viii 第一章緒論 1 第一節 研究動機 1 第二節 研究目的 4 第三節 研究問題 4 第四節 名詞界定 4 第二章文獻探討 6 第一節 子宮頸癌的病因與診斷 6 第二節 子宮頸癌疾病分期與對患者的影響 7 第三節 子宮頸癌的同步化學放射線治療 8 第四節 癌症患者面對疾病與治療之生活經驗的相關研究 17 第三章 研究方法 29 第一節 研究設計 29 第二節 研究情境 30 第三節 研究對象 34 第四節 研究工具 35 第五節 資料收集 36 第六節 研究資料的記錄 42 第七節 資料分析 42 第八節 資料收集與分析的嚴謹度 43 第九節 研究的倫理考量 45 第四章 研究結果 46 第一節 個案基本資料 46 第二節 子宮頸癌患者接受同步化學放射線治療期間的生活經驗 48 第五章 討論 126 第六章 結論 135 附錄一.......................................................................................................................151 附錄二.......................................................................................................................155 | |
dc.language.iso | zh-TW | |
dc.title | 子宮頸癌婦女接受同步化學放射線治療期間的生活經驗 | zh_TW |
dc.title | The Lived Experience of the Women with Cervical Cancer During Concurrent Chemoradiotherapy | en |
dc.type | Thesis | |
dc.date.schoolyear | 97-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 楊雅玲,陳祈安 | |
dc.subject.keyword | 子宮頸癌,同步化學放射線治療,生活經驗, | zh_TW |
dc.subject.keyword | cervical cancer,concurrent chemoradiotherapy,lived experiences, | en |
dc.relation.page | 160 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2009-08-20 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 護理學研究所 | zh_TW |
顯示於系所單位: | 護理學系所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-98-1.pdf 目前未授權公開取用 | 1.22 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。